Figure 5 | Scientific Reports

Figure 5

From: Longitudinal change in castration-resistant prostate cancer biomarker AST/ALT ratio reflects tumor progression

Figure 5

Kaplan–Meier analysis of overall survival and time to castration resistance in 81 mCRPC patients according to tumor volume and AST/ALT ratio. (A,B) The accuracy of predicting OS and TTCR in patients with advanced mCRPC from mHSPC classified by tumor burden was improved by subdividing by AST/ALT ratio. Low-volume patients with a high AST/ALT ratio had a similar poor prognosis and short TTCR as compared to high-volume patients with a high AST/ALT ratio.

Back to article page